Comparative Study of Hypo-Fractionated Radiotherapy Versus Conventional Radiotherapy in Breast Cancer

被引:0
|
作者
Narwariya, Abhinav [1 ]
Dhakar, Mhendr [2 ]
Jatav, Jagannath [3 ]
Prajapati, Raju [4 ]
Bayer, Sujata [5 ]
Moosa, Shajiya Sarwar [5 ]
Shaikh, Mohammad Habeebur Raheman [5 ]
Ali, Mohammed Taher [6 ]
Ahmad, Arafat [7 ]
Begum, Yousuf [5 ]
Hiware, Sanket D. [5 ]
机构
[1] Apollo Hosp, Med Oncol, New Delhi, India
[2] All India Inst Med Sci, Radiat Oncol, Raipur, India
[3] Shyam Shah Med Coll & Sanjay Gandhi Mem Hosp, Pathol, Rewa, India
[4] Shyam Shah Med Coll & Sanjay Gandhi Mem Hosp, Radiat Oncol, Rewa, India
[5] Imam Abdulrahman Bin Faisal Univ, Anat, Dammam, Saudi Arabia
[6] Imam Abdulrahman Bin Faisal Univ, Clin Pharmacol, Dammam, Saudi Arabia
[7] Imam Abdulrahman Bin Faisal Univ, Biochem, Dammam, Saudi Arabia
关键词
breast cancer radiotherapy; hypofractionation; lumpectomy; mastectomy; conventional radiotherapy; RADIATION-THERAPY; WOMEN; RISK;
D O I
10.7759/cureus.29147
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Breast cancer is the most commonly diagnosed cancer causing death among females worldwide. Radiotherapy after lumpectomy/mastectomy in breast cancer cases is a successful treatment modality taking five weeks to complete. The aim of the present study is to compare the effectiveness of hypo-fractionated radiotherapy in breast cancer patients with conventional radiotherapy with respect to outcome and toxicity.Methods: Sixty patients were randomly divided equally into a conventional group, Group A (dose: 50 Gy in 25 fractions), and a hypo-fractionated short-course radiotherapy group, Group B (dose: 40 Gy in 16 fractions). After thorough clinical and laboratory examination of all patients, the disease status was assessed prior to radiotherapy and three and six months after completion of radiotherapy. The cardiopulmonary function was assessed using echocardiography and pulmonary function tests prior to the procedure. The assessment of the development of toxicity (dysphagia, skin, lung, and lymphedema) was done during every clinical visit.Results: The mean age of patients was 53.28 +/- 9.73 years in Group A, and 55.67 +/- 10.41 years in Group B (p=0.82). The right breast was involved in 13 (43.4%) patients in Group A and 14 (46.6%) in Group B, and the left breast was involved n 17 (56.6%) patients in Group A and 16 (53.4%) in Group B (p=0.81). Most of the patients were post-menopausal; 24 (80%) in Group A and 25 (83.4%) in Group B (p=0.91). Eleven (36.6%) patients were of stage T2N1M0 in both groups. However, no statistical difference was observed between the groups in the TNM (tumor, node, and metastasis) staging using the AJCC (American Joint Committee on Cancer) criteria (p=0.26). On comparing the responses in Group A and Group B, no significant difference was observed in either of the groups from immediate post-treatment to the 12-month follow-up period (p=0.53 and p=0.64, respectively).Conclusion: Hypo-fractionated radiotherapy is as effective as conventional radiotherapy and can be used as an alternative method for treatment following breast cancer surgery.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] A PROSPECTIVE STUDY TO COMPARE HYPO-FRACTIONATED RADIOTHERAPY VERSUS CONVENTIONAL RADIOTHERAPY IN CARCINOMA BREAST
    Kumar, Sunny
    Singh, Sharad
    Prasad, S. N.
    Korde, Mangesh
    Elhence, Aditya
    Shakya, Vaibhav
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2019, 10 (04): : 2071 - 2078
  • [2] Radiobiological evaluation of hypo-fractionated breast cancer radiotherapy regimens in comparison with conventional approaches
    Arjmand, Bahare
    Chegeni, Nahid
    Danyaei, Amir
    Bagheri, Ali
    Razzaghi, Samira
    Rasouli, Naser
    Karimi, Arezoo
    Saki-Malehi, Amal
    Hazbavi, Maryam
    Mahmoudi, Farshid
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2024, 23
  • [3] Randomized study of conventional versus hypo-fractionated radiotherapy in diffuse intrinsic pontine glioma
    Izzuddeen, Yousra
    Gupta, Subhash
    Haresh, K. P.
    Giridhar, Prashanth
    Kashyap, Lakhan
    Rath, Goura Kisor
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] A prospective randomized comparative study to evaluate the effect of palliative hypo-fractionated radiotherapy with concurrent chemotherapy versus hypo-fractionated radiotherapy alone in advanced and unresectable head and neck cancer with no metastasis
    Uttam, Aditya Kumar
    Yadav, Arun Kumar
    Jalota, Shreya
    Singh, Renu
    Malik, Shivani
    Arya, Ashok Kumar
    ECANCERMEDICALSCIENCE, 2023, 17
  • [5] Impact of Breast volume on Skin toxicities during Hypo-fractionated Radiotherapy in Breast cancer
    Jribi, A.
    Fourati, N.
    Dhouib, F.
    Siala, W.
    Mnejja, W.
    Daoud, J.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S2117 - S2117
  • [6] Hypo-fractionated Radiotherapy (HF-RT) Versus Conventionally Fractionated Radiotherapy (CF-RT) for Glioblastoma
    Zemskova, Oksana
    Pedachenko, Eugene
    Yu, Nathan Y.
    Rades, Dirk
    ANTICANCER RESEARCH, 2023, 43 (07) : 3121 - 3128
  • [7] Retrospective Analysis of Efficacy and Toxicity of Hypo-fractionated Radiotherapy in Breast Carcinoma
    Mishra, Ritusha
    Khurana, Rohini
    Mishra, Himanshu
    Rastogi, Madhup
    Hadi, Rahat
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (08) : XC1 - XC3
  • [8] Clinical Outcomes of Patients with Metastatic Breast Cancer Treated with Hypo-Fractionated Liver Radiotherapy
    Mushonga, Melinda
    Helou, Joelle
    Weiss, Jessica
    Dawson, Laura A.
    Wong, Rebecca K. S.
    Hosni, Ali
    Kim, John
    Brierley, James
    Koch, C. Anne
    Alrabiah, Khalid
    Lindsay, Patricia
    Stanescu, Teo
    Barry, Aisling
    CANCERS, 2023, 15 (10)
  • [9] A pilot study: Utilization of PROMs in hypo-fractionated radiotherapy for localized prostate cancer
    Crowther, K.
    Shiels, P.
    Cole, A.
    Shepherd, P.
    Jain, S.
    Mitchell, D.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S624 - S624
  • [10] Hypo-Fractionated Radiotherapy for Laryngeal Cancer; is Linac Based Treatment Better?
    Kumar, Suresh K.
    Asokan, Anu
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2019, 8 (52): : 3946 - 3952